GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Accent Microcell Ltd (NSE:ACCENTMIC) » Definitions » Operating Income

Accent Microcell (NSE:ACCENTMIC) Operating Income : ₹374 Mil (TTM As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Accent Microcell Operating Income?

Accent Microcell's Operating Income for the six months ended in Mar. 2024 was ₹374 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Mar. 2024 was ₹374 Mil.

Operating Margin % is calculated as Operating Income divided by its Revenue. Accent Microcell's Operating Income for the six months ended in Mar. 2024 was ₹374 Mil. Accent Microcell's Revenue for the six months ended in Mar. 2024 was ₹2,455 Mil. Therefore, Accent Microcell's Operating Margin % for the quarter that ended in Mar. 2024 was 15.23%.

Accent Microcell's 5-Year average Growth Rate for Operating Margin % was 0.00% per year.

Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Accent Microcell's annualized ROC % for the quarter that ended in Mar. 2024 was 33.42%. Accent Microcell's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 44.10%.


Accent Microcell Operating Income Historical Data

The historical data trend for Accent Microcell's Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Accent Microcell Operating Income Chart

Accent Microcell Annual Data
Trend Mar21 Mar22 Mar23 Mar24
Operating Income
88.47 91.94 149.18 373.81

Accent Microcell Semi-Annual Data
Mar21 Mar22 Mar23 Mar24
Operating Income 88.47 91.94 149.18 373.81

Accent Microcell Operating Income Calculation

Operating Income, is the profit a company earned through operations. All expenses, including cash expenses such as cost of goods sold (COGS), research & development, wages, and non-cash expenses, such as depreciation, depletion and amortization, have been deducted from the sales.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Operating Income for the trailing twelve months (TTM) ended in Mar. 2024 was ₹374 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Accent Microcell  (NSE:ACCENTMIC) Operating Income Explanation

1. Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Accent Microcell's annualized ROC % for the quarter that ended in Mar. 2024 is calculated as:

ROC % (Q: Mar. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Mar. 2023 ) + Invested Capital (Q: Mar. 2024 ))/ count )
=373.805 * ( 1 - 17.41% )/( (731.361 + 1116.414)/ 2 )
=308.7255495/923.8875
=33.42 %

where

Invested Capital(Q: Mar. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1106.941 - 355.082 - ( 20.498 - max(0, 536.72 - 776.183+20.498))
=731.361

Invested Capital(Q: Mar. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=2048.397 - 208.543 - ( 723.44 - max(0, 378.58 - 1634.42+723.44))
=1116.414

Note: The Operating Income data used here is one times the annual (Mar. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Accent Microcell's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Mar. 2023  Q: Mar. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=375.225/( ( (310.17 + max(367.414, 0)) + (399.097 + max(624.944, 0)) )/ 2 )
=375.225/( ( 677.584 + 1024.041 )/ 2 )
=375.225/850.8125
=44.10 %

where Working Capital is:

Working Capital(Q: Mar. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(303.54 + 419.406 + 7.814) - (355.082 + 0 + 8.264)
=367.414

Working Capital(Q: Mar. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(538.042 + 329.832 + 22.722) - (208.543 + 0 + 57.109)
=624.944

When net working capital is negative, 0 is used.

Note: The EBIT data used here is one times the annual (Mar. 2024) EBIT data.

3. Operating Income is also linked to Operating Margin %:

Accent Microcell's Operating Margin % for the quarter that ended in Mar. 2024 is calculated as:

Operating Margin %=Operating Income (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=373.805/2454.978
=15.23 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

4. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Operating Income growth rate using Operating Income per share data.


Be Aware

Compared with a company's EBITDA margin, Operating Margin can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin may decline. Often the Operating Margin declines well before the company's revenue or even profit decline. Therefore, Operating Margin is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia's Operating Margin had already been in decline since 2002, although its earnings per share were still rising. Investors who paid attention to Operating Margin would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Accent Microcell Operating Income Related Terms

Thank you for viewing the detailed overview of Accent Microcell's Operating Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Accent Microcell Business Description

Traded in Other Exchanges
N/A
Address
Shyamal Cross Roads, Anandnagar Road, 314, Shangrilla Arcade, Satellite, Ahmedabad, GJ, IND, 380015
Accent Microcell Ltd is engaged in the manufacturing business of pharmaceutical excipients including products like Microcrystalline Cellulose which is a term for refined wood pulp and is used as a texturizer, an anti-caking agent, a fat substitute, an emulsifier, an extender, and a bulking agent in food production; Croscarmellose Sodium used as a super disintegrant in pharmaceutical formulations; Magnesium Stearate; Cellulose Powder, and others. Its business segments are segregated based on the location of its manufacturing facilities and include Dahej (SEZ Unit) which generates maximum revenue, Pirana, Unit III, and Inter Unit Sales. Geographically, a majority of the company's revenue is derived through the export of its products to various countries.

Accent Microcell Headlines

No Headlines